|Basic InformationLookupsLatest News|A Shot of Caffeine May Speed Wake-Up After AnesthesiaZika Hijacks Pregnant Woman's Immune SystemHernia Patients May Need Fewer Opioids After Surgery, Study FindsHealth Tip: Prevent DehydrationTravel Tips for Contact Lens WearersHigher Odds of Infection With Reduced Kidney FunctionMost Ulcerative Colitis Patients Do Not Achieve Target RemissionOral Contraceptive Use Linked to Lower Rheumatoid Arthritis RiskKidney Disease May Boost Odds of InfectionZika May Not Last in Semen as Long as ThoughtVirtual House Calls for Speedy, Effective Parkinson's CareNearly 4 Million Worldwide Die Each Year From Asthma, COPDPowerful New Cholesterol Med Won't Harm Memory, Easing ConcernsDiverse Spectrum of Neurologic Syndromes Seen With ZikaExposure to Particulate Matter Linked to Metabolic AlterationsAir Purifiers May Help the Smog-Stressed Heart'Fat But Fit' a Myth?Statin Use Among Nursing Home Residents Varies SignificantlyZika Virus Tied to Neurological Woes in AdultsAn Expert's Guide to Preventing Food PoisoningHeart Risk Up if Hospitalized for Pneumonia or SepsisSinging May Be Good Medicine for Parkinson's PatientsCPAP Doesn't Alter Renal Function in Coexisting OSA, CVDWhen Stress Hormone Falters, Your Health May SufferKidney Disease May Boost Risk of Abnormal HeartbeatCertain Jobs Linked to Raised Risk of Rheumatoid ArthritisMidlife Vascular Risk Factors Tied to Increased Risk of DementiaHigher Risk of CVD Persists After Hospital Stay for Severe InfectionAntibiotic Doesn't Prevent Lung Complication After Stem Cell TransplantHealth Tip: One of Three Adults Gets ShinglesBlood Pressure Fluctuations Tied to Dementia Risk in StudyDecline in Kids' Ear Infections Linked to Pneumococcal VaccineFDA Approves Mavyret for Hepatitis CDoes Less Sleep Make You Less Healthy?Diabetes Drug Shows Promise Against Parkinson'sReview Suggests Benefits of Aerobic Exercise in FibromyalgiaNovel Procedure Improves Kidney Transplant SuccessABP 501, Adalimumab Biosimilar, Safe and Effective, for PsoriasisSimilar Defects ID'd for T2DM, Chronic Pancreatitis and DiabetesScientists Gain Insight Into AllergiesHealth Tip: Cooling a Heat RashKnow the Signs of ConcussionDo Your Pearly Whites Sometimes Cause You Pain?Rates of Inflammatory Bowel Disease Down in Rural AreasZika Probably Not Spread Through Saliva: StudyDrug for Kidney Disease Tied to Infection RiskGum Disease May Be Linked to Cancer Risk in Older WomenStent Surgery Could Benefit Select Glaucoma PatientsBlood Proteins Linked to Severity of Chronic Fatigue SyndromeDrowning Can Occur Hours After SwimmingQuestions and AnswersLinksBook Reviews
Bedbugs Building Resistance to More Insecticides
by -- Robert Preidt
Updated: Apr 10th 2017
MONDAY, April 10, 2017 (HealthDay News) -- The bedbugs are winning.
Some bedbugs are showing early signs of resistance to two widely used insecticides, Purdue University researchers report.
As a result, the researchers urge pest management companies to use a "well-rounded" set of control measures when dealing with the parasitic insects.
"In the past, bedbugs have repeatedly shown the ability to develop resistance to products overly relied upon for their control," said study author Ameya Gondhalekar, a research assistant professor at Purdue's Center for Urban and Industrial Pest Management.
"The findings also show similar trends in regard to chlorfenapyr and bifenthrin resistance development in bedbugs," Gondhalekar said in a news release from the Entomological Society of America.
Previously, common bedbugs were found to have significant resistance to deltamethrin and some other pyrethroid-class insecticides. That has led to their re-emergence as an urban pest, the study authors explained.
For this study, the researchers tested 10 populations of bedbugs gathered from locations in Indiana, New Jersey, Ohio, Tennessee, Virginia and Washington, D.C. The investigators found that more than 25 percent of the pests were still alive seven days after exposure to the insecticides chlorfenapyr and bifenthrin.
That rate of survival indicates resistance to the insecticides, the study authors said.
Further research is needed to learn why certain bedbugs can survive exposure to the two insecticides, Gondhalekar's team suggested.
Integrated pest management practices will slow further development of bedbug resistance to the chemicals, the researchers said.
"With these findings in mind and from an insecticide-resistance management perspective, both bifenthrin and chlorfenapyr should be integrated with other methods used for bedbug elimination in order to preserve their [effectiveness] in the long term," Gondhalekar recommended.
The other control measures include vacuuming, steam or heat treatments, mattress encasements, traps, and a professional insecticide called desiccant dusts.
With a multipronged approach, "effective bedbug control can be accomplished, and theoretically this should reduce the risk of resistance build-up in populations," Gondhalekar said.
The study results were published April 10 in the Journal of Economic Entomology.
The U.S. Centers for Disease Control and Prevention has more on bedbugs.
This article: Copyright © 2017 HealthDay. All rights reserved.